Jabil Photonics and EFFECT Photonics to Co-Develop Next-Generation Coherent Modules
SAN DIEGO–(BUSINESS WIRE)–Jabil (NYSE: JBL) today announced that its Photonics business unit, a leading provider…
SAN DIEGO–(BUSINESS WIRE)–Jabil (NYSE: JBL) today announced that its Photonics business unit, a leading provider…
SAN DIEGO–(BUSINESS WIRE)–Jabil (NYSE: JBL) today announced that its Photonics business unit, a leading provider…
NEEDHAM, Mass.–(BUSINESS WIRE)–#ITMarkets–The Russian invasion of Ukraine and the resulting diplomatic and economic response have…
WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–PennyMac Mortgage Investment Trust (NYSE: PMT) announced today that Catherine A. Lynch,…
Optii Solutions Will Help Curator Member Hotels to Streamline Daily Operations BETHESDA, Md. & AUSTIN,…
Formerly known as the Allscripts Application Store, the refreshed site includes global tags and dedicated…
Collaborating to bring to market a new high performance and low power edge AI processor….
Increased DSS Fee Combined with Lower Operating Costs and Rental Fleet Deployments to Improve Financial…
Banking solution simplifies branch execution, communication and inspections LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Zebra Technologies, an innovator at…
Prophylactic Hepatitis B (HBV): FDA approval of PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] received in November…
Scale Microgrid Solutions (“Scale”), a Warburg Pincus portfolio company, announced today that it has acquired…
Executives from Coinbase, Cooley LLP, Marsh, State Street and others join industry leading MPC product…
WATERTOWN, Mass., March 07, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
The parties have entered into a collaboration agreement to develop Targovax´s TG mutant KRAS cancer…
An Investigator Initiated Phase 2 Clinical Trial of TNX-1900 In Patients with Binge Eating Disorder…
VYN201 0.1% and 1% resulted in statistically significant improvement in reducing both melanocyte loss and…
XHANCE met both co-primary endpoints in the ReOpen1 trial, demonstrating statistically significant benefits on symptoms…
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 07, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
– Initiated DELTA-1, a Phase 2 trial of ITIL-168 in advanced melanoma with registrational intent…
Q4 2021 net loss was $(0.48) per basic and diluted share and adjusted non-GAAP net…